Medical College of Wisconsin
CTSICores SearchResearch InformaticsREDCap

Faculty who have authored publication Activity of the oral MEK inhibitor trametinib in patients with advanced melanoma: a phase 1 dose-escalation trial.

NameTitleDepartmentInstitution
Razelle Kurzrock MDCenter Associate Director, ProfessorMedicineMedical College of Wisconsin